New gut damage test could help ICU doctors spot hidden injury

NCT ID NCT07440368

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at a protein called I-FABP, which is released when gut cells are damaged. Researchers will measure it in the blood and urine of 500 ICU patients to see if it relates to how severe their gastrointestinal problems are. No treatments are given—this is purely to gather information and improve how doctors assess gut health in critical illness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a more objective way to diagnose and grade gut injury in critically ill patients, improving care.

What could go wrong

This is an observational study, so it won't test any treatment. The biomarker may not prove useful in real-world settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••